MLSS
Price
$0.56
Change
-$0.02 (-3.45%)
Updated
Apr 19, 6:59 PM EST
24 days until earnings call
TRIB
Price
$1.79
Change
-$0.01 (-0.56%)
Updated
Apr 19, 6:59 PM EST
17 days until earnings call
Ad is loading...

MLSS vs TRIB ᐉ Comparison: Which is Better to Invest?

Header iconMLSS vs TRIB Comparison
Open Charts MLSS vs TRIBBanner chart's image
Milestone Scientific
Price$0.56
Change-$0.02 (-3.45%)
Volume$49.88K
CapitalizationN/A
Trinity Biotech
Price$1.79
Change-$0.01 (-0.56%)
Volume$3.63K
CapitalizationN/A
View a ticker or compare two or three
MLSS vs TRIB Comparison Chart

Loading...

MLSSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TRIBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
MLSS vs. TRIB commentary
Apr 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLSS is a Hold and TRIB is a Sell.

COMPARISON
Comparison
Apr 20, 2024
Stock price -- (MLSS: $0.57 vs. TRIB: $1.88)
Brand notoriety: MLSS and TRIB are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MLSS: 115% vs. TRIB: 120%
Market capitalization -- MLSS: $47.46M vs. TRIB: $14.9M
MLSS [@Medical Specialties] is valued at $47.46M. TRIB’s [@Medical Specialties] market capitalization is $14.9M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLSS’s FA Score shows that 0 FA rating(s) are green whileTRIB’s FA Score has 1 green FA rating(s).

  • MLSS’s FA Score: 0 green, 5 red.
  • TRIB’s FA Score: 1 green, 4 red.
According to our system of comparison, TRIB is a better buy in the long-term than MLSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLSS’s TA Score shows that 2 TA indicator(s) are bullish while TRIB’s TA Score has 5 bullish TA indicator(s).

  • MLSS’s TA Score: 2 bullish, 5 bearish.
  • TRIB’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TRIB is a better buy in the short-term than MLSS.

Price Growth

MLSS (@Medical Specialties) experienced а +0.14% price change this week, while TRIB (@Medical Specialties) price change was +2.73% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.24%. For the same industry, the average monthly price growth was -4.56%, and the average quarterly price growth was +9.29%.

Reported Earning Dates

MLSS is expected to report earnings on Aug 13, 2024.

TRIB is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Medical Specialties (-2.24% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for MLSS with price predictions.
OPEN
A.I.dvisor published
a Summary for TRIB with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MLSS($47.5M) has a higher market cap than TRIB($14.9M). TRIB YTD gains are higher at: -12.354 vs. MLSS (-17.176). MLSS has higher annual earnings (EBITDA): -6.99M vs. TRIB (-26.34M). TRIB has more cash in the bank: 6.58M vs. MLSS (4.62M). MLSS has less debt than TRIB: MLSS (422K) vs TRIB (67.3M). TRIB has higher revenues than MLSS: TRIB (71.4M) vs MLSS (9.81M).
MLSSTRIBMLSS / TRIB
Capitalization47.5M14.9M319%
EBITDA-6.99M-26.34M27%
Gain YTD-17.176-12.354139%
P/E RatioN/A33.00-
Revenue9.81M71.4M14%
Total Cash4.62M6.58M70%
Total Debt422K67.3M1%
FUNDAMENTALS RATINGS
MLSS vs TRIB: Fundamental Ratings
MLSS
TRIB
OUTLOOK RATING
1..100
5653
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
69
Overvalued
PROFIT vs RISK RATING
1..100
89100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
8486
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRIB's Valuation (69) in the Medical Specialties industry is in the same range as MLSS (95). This means that TRIB’s stock grew similarly to MLSS’s over the last 12 months.

MLSS's Profit vs Risk Rating (89) in the Medical Specialties industry is in the same range as TRIB (100). This means that MLSS’s stock grew similarly to TRIB’s over the last 12 months.

MLSS's SMR Rating (98) in the Medical Specialties industry is in the same range as TRIB (100). This means that MLSS’s stock grew similarly to TRIB’s over the last 12 months.

MLSS's Price Growth Rating (84) in the Medical Specialties industry is in the same range as TRIB (86). This means that MLSS’s stock grew similarly to TRIB’s over the last 12 months.

TRIB's P/E Growth Rating (2) in the Medical Specialties industry is significantly better than the same rating for MLSS (100). This means that TRIB’s stock grew significantly faster than MLSS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MLSSTRIB
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 23 days ago
86%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 25 days ago
90%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
MLSSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TRIBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QNCX1.060.06
+6.00%
Quince Therapeutics
HOPE10.420.14
+1.36%
Hope Bancorp
ISPR5.770.06
+1.05%
Ispire Technology
FCX50.160.34
+0.68%
Freeport-McMoran
CADE26.37-0.25
-0.94%
Cadence Bank

MLSS and

Correlation & Price change

A.I.dvisor tells us that MLSS and SRDX have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MLSS and SRDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLSS
1D Price
Change %
MLSS100%
+0.23%
SRDX - MLSS
26%
Poorly correlated
-0.49%
VTAK - MLSS
25%
Poorly correlated
+8.60%
ACRS - MLSS
24%
Poorly correlated
N/A
ARAY - MLSS
24%
Poorly correlated
+0.91%
NSPR - MLSS
23%
Poorly correlated
-3.13%
More

TRIB and

Correlation & Price change

A.I.dvisor tells us that TRIB and NVRO have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TRIB and NVRO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRIB
1D Price
Change %
TRIB100%
+2.17%
NVRO - TRIB
31%
Poorly correlated
+0.24%
RGEN - TRIB
28%
Poorly correlated
-2.44%
NVCR - TRIB
26%
Poorly correlated
N/A
CODX - TRIB
24%
Poorly correlated
+1.75%
UFPT - TRIB
23%
Poorly correlated
-3.50%
More